Kolon Industries, Inc. (120110.KS)
KRW 28950.0
(-1.86%)
KRW 28950.0
(-1.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5061.15 Billion | 5367.47 Billion | 4662.05 Billion | 4036.08 Billion | 4407.19 Billion | 4752.57 Billion |
| Cost of Revenue | 3769.76 Billion | 3886.29 Billion | 3360.17 Billion | 2999.24 Billion | 3276.08 Billion | 3636.42 Billion |
| Gross Profit | 1291.39 Billion | 1481.17 Billion | 1301.87 Billion | 1036.84 Billion | 1131.1 Billion | 1116.15 Billion |
| Operating Expenses | 1134.76 Billion | 1238.67 Billion | 1049.16 Billion | 884.24 Billion | 958.15 Billion | 971.23 Billion |
| Selling, General and Administrative Expenses | 720.53 Billion | 805.05 Billion | 646.3 Billion | 491.43 Billion | 579.92 Billion | 586.69 Billion |
| Research and Development Expenses | 77.49 Billion | 74.23 Billion | 73.33 Billion | 66.4 Billion | 66.17 Billion | 66.83 Billion |
| Other Expenses | 366.12 Billion | 359.38 Billion | 329.52 Billion | 326.4 Billion | 312.05 Billion | 59.85 Billion |
| Cost and Expenses | 4904.52 Billion | 5124.97 Billion | 4409.33 Billion | 3883.48 Billion | 4234.24 Billion | 4607.66 Billion |
| Operating Income | 157.62 Billion | 242.49 Billion | 252.71 Billion | 152.44 Billion | 172.94 Billion | 144.91 Billion |
| Interest Expense | 108.35 Billion | 69.9 Billion | 43.25 Billion | 57.7 Billion | 77.85 Billion | 69.61 Billion |
| Income Tax Expense | 38.84 Billion | -16.86 Billion | 53.47 Billion | 107.3 Billion | 24.07 Billion | 47.33 Billion |
| Earnings before Tax | 89.62 Billion | 169.69 Billion | 278.05 Billion | 309.23 Billion | 83.43 Billion | 90.26 Billion |
| Net Income | 42.75 Billion | 179.82 Billion | 189.15 Billion | 203.43 Billion | 59.35 Billion | 65.02 Billion |
| Earnings Per Share Basic | 1061.00 | 5938.76 | 6341.13 | 6838.76 | 1995.47 | 2252.00 |
| Earnings Per Share Diluted | 1249.49 | 5754.38 | 6124.85 | 6665.68 | 1995.47 | 2236.00 |
| Weighted Average Shares Outstanding | 36.71 Million | 30.27 Million | 29.83 Million | 29.74 Million | 29.74 Million | 28.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.17 Million | 31.25 Million | 30.88 Million | 30.51 Million | 29.74 Million | 29.08 Million |
| Gross Margin | 0.26 | 0.28 | 0.28 | 0.26 | 0.26 | 0.23 |
| EBIT Margin | 0.08 | 0.09 | 0.12 | 0.11 | 0.10 | 0.09 |
| Profit Margin | 0.01 | 0.03 | 0.04 | 0.05 | 0.01 | 0.01 |
| EBITDA | 408.86 Billion | 482.13 Billion | 503.22 Billion | 599.93 Billion | 400.08 Billion | 397.04 Billion |
| Earnings Before Tax Margin | 0.03 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1283.97 Billion | 1161.19 Billion | 1301.4 Billion | 5061.15 Billion | 1183.34 Billion | 1347.21 Billion |
| Cost of Revenue | 932.46 Billion | 865.39 Billion | 932.66 Billion | 3769.76 Billion | 898.73 Billion | 987.46 Billion |
| Gross Profit | 351.51 Billion | 295.79 Billion | 368.73 Billion | 1291.39 Billion | 284.61 Billion | 359.75 Billion |
| Operating Expenses | 292.5 Billion | 265.25 Billion | 327.52 Billion | 1134.76 Billion | -262.59 Billion | -293.94 Billion |
| Selling, General and Administrative Expenses | 261.01 Billion | 235.7 Billion | 294.45 Billion | - | 262.59 Billion | 293.94 Billion |
| Research and Development Expenses | 27.86 Billion | 28.12 Billion | 31.62 Billion | - | 19.05 Billion | 18.82 Billion |
| Other Expenses | -3.61 Billion | -1.42 Billion | -1.44 Billion | -7.91 Billion | -525.19 Billion | -587.88 Billion |
| Cost and Expenses | 1224.97 Billion | 1130.64 Billion | 1260.18 Billion | 4904.52 Billion | 898.73 Billion | 987.46 Billion |
| Operating Income | 59 Billion | 30.54 Billion | 41.21 Billion | 156.63 Billion | 22.01 Billion | 65.81 Billion |
| Interest Expense | - | 26.57 Billion | 25.39 Billion | 108.35 Billion | 27.66 Billion | 27.83 Billion |
| Income Tax Expense | 2.23 Billion | 1.37 Billion | -2.18 Billion | 38.84 Billion | 6.03 Billion | 24.83 Billion |
| Earnings before Tax | 43.52 Billion | 26.05 Billion | -13.07 Billion | 57.24 Billion | -366.79 Million | 61.54 Billion |
| Net Income | 41.2 Billion | 14.13 Billion | -9.2 Billion | 42.75 Billion | -8.75 Billion | 35.5 Billion |
| Earnings Per Share Basic | 1235.20 | 466.71 | -303.93 | - | -289.16 | 1172.43 |
| Earnings Per Share Diluted | 1202.71 | 454.21 | -303.93 | - | -289.16 | 1139.07 |
| Weighted Average Shares Outstanding | 30.27 Million | 30.27 Million | 30.27 Million | 30.27 Million | 30.27 Million | 30.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.09 Million | 31.11 Million | 30.27 Million | 31.17 Million | 30.27 Million | 31.16 Million |
| Gross Margin | 0.27 | 0.25 | 0.28 | 0.26 | 0.24 | 0.27 |
| EBIT Margin | 0.10 | 0.08 | 0.08 | - | 0.24 | 0.27 |
| Profit Margin | 0.03 | 0.01 | -0.01 | 0.01 | -0.01 | 0.03 |
| EBITDA | 124.92 Billion | 95.25 Billion | 104.26 Billion | - | 284.61 Billion | 359.75 Billion |
| Earnings Before Tax Margin | 0.05 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 |
301160
SLVMF
DRMA
0HRS
STYRENIX
EICHERMOT